Commercial Products

Commercial Focus

Neos Therapeutics, Inc. (Neos Therapeutics) is focused on developing, manufacturing, and commercializing innovative extended-release products that utilize our proprietary extended-release drug delivery technology platform. Our technology allows us to develop extended-release ODT or extended-release oral suspension formulations of existing extended-release medications.

Products

Adzenys XR-ODT® (amphetamine)

Please see Important Safety Information, including Boxed WARNING for abuse and dependence, and Full Prescribing Information.

» Learn More

Adzenys XR-ODT® is a Registered Trademark of Neos Therapeutics.

Cotempla XR-ODT (methylphenidate)

Please see Important Safety Information, including Boxed WARNING for abuse and dependence, and Full Prescribing Information.

» Learn More

Cotempla XR-ODT is a trademark of Neos Therapeutics.

Hydrocodone polistirex and chlorpheniramine polistirex extended-release (XR) liquid suspension

Please see Full Prescribing Information, including Boxed WARNING.